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ABSTRACT
Recent pre-clinical and clinical studies have suggested that endogenous cardiospheres (eCS) are
potentially safe and effective for cardiac regeneration following myocardial infarction (MI). Nev-
ertheless the preparation of autologous eCS requires invasive myocardial biopsy with limited
yield. We describe a novel approach to generate induced cardiospheres (iCS) from adult skin
ﬁbroblasts via somatic reprogramming. After infection with Sox2, Klf4, and Oct4, iCS were gen-
erated from mouse adult skin ﬁbroblasts treated with Gsk3b inhibitor-(20Z,30E)- 6-
Bromoindirubin-30-oxime and Oncostatin M. They resembled eCS, but contained a higher per-
centage of cells expressing Mesp1, Isl1, and Nkx2.5. They were differentiated into functional
cardiomyocytes in vitro with similar electrophysiological properties, calcium transient and con-
tractile function to eCS and mouse embryonic stem cell-derived cardiomyocytes. Transplantation
of iCS (1 3 106 cells) into mouse myocardium following MI had similar effects to transplanta-
tion of eCS but signiﬁcantly better than saline or ﬁbroblast in improving left ventricular ejection
fraction, increasing anterior/septal ventricular wall thickness and capillary density in the infarct-
ed region 4 weeks after transplantation. No tumor formation was observed. iCS generated from
adult skin ﬁbroblasts by somatic reprogramming and a cocktail of Gsk3b inhibitor-6-
Bromoindirubin-30-oxime and Oncostatin M may represent a novel source for cell therapy in MI.
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SIGNIFICANCE STATEMENT
This study provides the first proof-of-principle results that demonstrate the feasibility of gener-
ating donor-specific induced cardiospheres via a somatic reprogramming process, providing a
new source of cell therapy for treatment of myocardial infarction
INTRODUCTION
Cardiovascular diseases (CVDs), especially myo-
cardial infarction (MI), are the leading cause of
death worldwide and contribute to over 30%
of global mortality [1, 2]. Despite recent
advances in the treatment of CVDs, a signiﬁ-
cant proportion of patients still die of progres-
sive heart failure. Therapy remains palliative
and does not address the fundamental patho-
genic process of CVDs, that is, loss of function-
al cardiomyocytes. As a result, cell-based
therapies have been proposed as a promising
strategy to treat CVDs via replenishment of
the damaged cells. Different types of stem
cells, including bone marrow stem cells, mes-
enchymal stem cells, skeletal myoblasts, endo-
thelial progenitor cells and cardiac progenitor
cells, have been investigated as sources for
cell therapy in myocardial regeneration [3–5].
Although improved heart function has been
observed in preclinical studies after transplan-
tation of non-heart origin stem cells into the
injured myocardium, there is very limited evi-
dence of myocardial regeneration via trans-
differentiation into functional cardiomyocytes
in vivo. Most studies have shown that the
improvement in cardiac function, especially
with bone marrow-derived cells, is due to
paracrine effects [6, 7]. On the contrary, it has
been demonstrated that various types of cardi-
ac progenitor cells, including endogenous car-
diospheres (eCS), can differentiate into
functional cardiomyocytes in vivo, and thus
may represent a more effective cell-based
therapy [8, 9].
Cardiac progenitor cells, residing in the
heart with the ability to differentiate into
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REGENERATIVE MEDICINE
three major cardiac cell types (cardiomyocyte, endothelial cell,
and smooth muscle cell), have been deﬁned and isolated
using different approaches, such as different marker-positive
cell population (cKit1 [10], Flk1 [11], Wt11 [12], Mesp11
[13], Isl11[14], and Nkx2.51[15]), side population [16] as
well as the eCS [8, 9]. These cardiac progenitor cells have
been consistently shown to improve heart function in differ-
ent pre-clinical small and large animal models of MI [17, 18].
Among them, eCS has been one of the most commonly used
cell sources for cardiac regeneration in animal models and
clinical studies [18–20].
Unfortunately, the therapeutic application of autologous
eCS is limited by the low yield of cell preparation as very few
exist in vivo and the need for highly invasive myocardial biop-
sy [9]. There is thus emerging interest in the generation of
cardiospheres using an alternative approach [21]. Previous
reports have demonstrated that mouse embryonic ﬁbroblasts
can be directly converted into cardiomyocytes through a
direct somatic reprogramming strategy; and this process
passed through a cardiac progenitor stage [22, 23]. To evalu-
ate the feasibility of isolating these cardiac progenitor cells
via the formation of cardiospheres during the somatic reprog-
ramming process, different panels of cardiotrophic growth fac-
tors or chemicals were screened.
Our results demonstrated that the combination of Gsk3b
inhibitor-(20Z,30E)- 6-Bromoindirubin-30-oxime (BIO), and
Oncostatin M (OSM) promoted the generation of spheres
from both embryonic ﬁbroblasts and adult skin ﬁbroblasts
during somatic reprogramming. These spheres, which resem-
ble eCS, contained Mesp1, Isl1, and Nkx2.5 positive cardiac
progenitor cells but not pluripotent stem cells and possessed
the differentiation ability of cardiomyocytes, thus they were
termed induced cardiospheres (iCS). These iCS had therapeutic
potential comparable with eCS in a mouse model of MI.
Therefore, we provide the ﬁrst proof-of-principle results to
show the feasibility of generating iCS for cardiac regeneration
by somatic reprogramming of mouse ﬁbroblasts without pass-
ing through a pluripotent stem cell stage by using a panel of
pluripotent transcription factors and cardiotrophic growth
factors.
MATERIALS AND METHODS
Cell Isolation and Maintenance
Adult skin ﬁbroblasts were isolated from 4-week-old mice.
Neonatal cardiomyocytes were isolated from 1 to 2 day old
neonatal mice. Adult cardiomyocytes were isolated from 4 to
6 weeks old mice using the Langendorff retrograde perfusion
method [24]. Endogenous cardiospheres were isolated as
described before [8, 9]. In brief, mouse eCS were isolated
from 4 weeks old mice. The mice were anesthetized with
ketamine (100 mg/kg) and xylazine (10 mg/kg), and their
hearts were removed quickly and incubated with cold Ca21
and Mg21 free phosphate buffered saline (PBS) (Invitrogen,
Grand Island, NY, USA, https://www.thermoﬁsher.com/hk/en/
home/brands/invitrogen.html). The heart was washed with
PBS via aorta perfusion, and then minced in the digestion
buffer (4 mg/ml collagenase B and 4 mg/ml dispase (Roche
Life Science, Penzberg, Germany, https://lifescience.roche.
com/) in DMEM/High Glucose) and digested for 30 minutes at
378C. The isolated single cells and tissue fragments were
washed twice with PBS and plated on a culture dish with cul-
ture medium (DMEM/High Glucose, 10% FBS (fetal bovine
serum), 100 U/ml penicillin, 100 lg/ml streptomycin, 2 mM L-
glutamine, and 0.1 mM 2-mercaptoethanol) at 378C and 5%
CO2. Medium was refreshed every 3 days. After 3–4 weeks,
the small, phase-bright cells were harvested through 0.53 mM
EDTA (Versene, Invitrogen) and 0.05% trypsin-EDTA (Invitro-
gen) treatment. Cells were plated onto a poly-D-lysine (Sigma,
St. Louis, MO, USA, http://www.sigmaaldrich.com/) coated
cell culture dish in cardiosphere-growing medium (35% com-
plete IMDM/65% DMEM–Ham F-12 mix containing 2% B27,
0.1 mM 2-mercaptoethanol, 10 ng/ml epidermal growth fac-
tor (EGF), 20 ng/ml basic ﬁbroblast growth factor (bFGF),
40 nM cardiotrophin-1, 40 nM thrombin, 100 U/ml penicillin,
100 mg/ml streptomycin and 2 mM L-glutamine). Three days
after plating, the eCS were formed and used for subsequent
experiments.
Mouse embryonic stem cells (mESC, cell line R1) were
maintained on 0.1% gelatin coated plates with culture medi-
um (DMEM/High Glucose, 15% FBS (HyClone, South Logan,
Utah, USA, http://www.gelifesciences.com/), 2 mM GlutaMAX,
1% nonessential amino acids, 0.1 mM 2-mercaptoethanol
(Gibco, Grand Island, NY, USA, https://www.thermoﬁsher.com/),
1% penicillin-streptomycin, and 1,000 U/ml leukemia inhibi-
tory factor (LIF, Millipore, Darmstadt, Germany, http://www.
emdmillipore.com/). The medium was refreshed every day.
Human dermal ﬁbroblasts (Thermo Fisher, Grand Island, NY,
USA, https://www.thermoﬁsher.com/) were maintained
according to manufacturer’s instructions.
iCS Generation and Differentiation
Retrovirus was produced by introducing pMXs-Oct4 (Addgene
13366, Cambridge, MA, USA, https://www.addgene.org/),
pMXs-Sox2 (Addgene 13367), and pMXs-Klf4 (Addgene 13370)
[25] and packaging plasmid pCL-Eco (Addgene 12371) [26]
into 293T cells with lipofectamine 2000 (Invitrogen). Forty-
eight hours after transfection, the viral supernatant was col-
lected and ﬁltered using a 0.45 lm PVDF-based ﬁlter for
somatic cell infection. Mouse adult skin ﬁbroblasts were plat-
ed on a 0.1% gelatin coated plate at a cell density of 2 3 104
cells per well. The ﬁbroblasts were infected overnight in the
presence of 8 lg/ml polybrene (Sigma). Then the medium
was changed to basal medium: DMEM/High Glucose, 10%
Knockout Serum Replacement, 2 mM GlutaMAX, 1% nones-
sential amino acids, 0.1 mM 2-mercaptoethanol, 0.5% N2
(Gibco) and 4 ng/ml bFGF (Peprotech, Rocky Hill, NJ, USA,
https://www.peprotech.com/) for induced cardiosphere gener-
ation. Growth factors or chemicals were added at a ﬁnal con-
centration of 20 ng/ml [EGF, bFGF, bone morphogenetic
protein 4 (BMP4), Interleukin 6 from Peprotech], 50 ng/ml
[vascular endothelial growth factor (VEGF), hepatocyte growth
factor (HGF), and Actinin A from Peprotech; and OSM from
Sigma], 100 ng/ml [Wnt3a, Cardiotrophin 1 (CT-1) from Pepro-
tech], 20 mM Lithium chloride (Sigma) and 2.5 lM BIO
(Sigma).
For knock down experiments, shRNA targeting to b-
catenin (shRNA target 50-GGTGCTGTCTGTCTGCTCTA-30) was
cloned into lentivirus pLKO.1 puro vector with AgeI and EcoRI
restriction sites (Addgene 8453) and the infection was con-
ducted at the same time as Oct4, Sox2, and Klf4 infection. For
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overexpression experiments, mouse b-catenin cDNA was ligat-
ed into the Sal1 and BamH1 site of the pMXs vector with
infection conducted at the same time as Oct4, Sox2, and Klf4
infection.
For spontaneous differentiation, newly formed iCS were
plated onto Matrigel (1:40, BD Biosciences, San Jose, CA, USA,
http://www.bdbiosciences.com/) coated plates with differenti-
ation medium (DMEM/High Glucose, 15% FBS (HyClone),
2 mM GlutaMAX, 1% nonessential amino acids, 0.1 mM 2-
mercaptoethanol (Gibco), 50 lg/ml Ascorbic acid (Sigma)) for
15 days. Beating area appeared at day 12 after differentiation
and the number increased till day 15. There was no obvious
further increasing of beating area after 15 days of differentia-
tion. This differentiation process is consistent in all experi-
ments performed. Beating areas were manually dissected and
digested with 1 mg/ml collagenase B for subsequent experi-
ments. The other differentiated cells were used for endotheli-
al and smooth muscle cell marker staining.
Similarly, spontaneous differentiation of eCS was per-
formed as described before [8, 9]. The eCS were plated onto
0.1% gelatin coated plates with cardiomyocytes differentiation
medium [DMEM/High Glucose, 15% FBS (HyClone), 2 mM
GlutaMAX, 1% nonessential amino acids, 0.1 mM 2-
mercaptoethanol (Gibco), 50 lg/ml Ascorbic acid (Sigma)].
The beating clusters from day 15 of differentiation were man-
ually picked out and digested with 1 mg/ml collagenase B for
2 hours at 378C, followed by 5 mM EDTA treatment for 5
minutes. The single cardiomyocytes were plated on 0.1% gela-
tin coated coverslips with cardiomyocyte differentiation medi-
um for 3 days and then used for subsequent experiments,
including ﬂow cytometry, action potential, calcium transient,
and contractility analysis.
mESC Differentiation
Cardiomyocyte differentiation of mESC was performed as
described before [27]. In brief, 1 3 106 cells were suspended
in 10 ml differentiation medium [DMEM/High Glucose, 15%
FBS (HyClone), 2 mM GlutaMAX, 1% nonessential amino acids,
0.1 mM 2-mercaptoethanol (Gibco), 50 lg/ml Ascorbic acid
(Sigma)] for 7 days to allow embryoid body (EB) formation.
On day 7, the EBs were plated onto 0.1% gelatin coated bac-
terial dishes for further differentiation. On day 9, beating
areas were observed in some EBs. The beating cluster from
day 15 of differentiation was manually picked out and
digested with 1 mg/ml collagenase B for 2 hours at 378C, fol-
lowed by 5 mM EDTA treatment for 5 minutes. The single car-
diomyocytes were plated on 0.1% gelatin coated coverslips
with cardiomyocyte differentiation medium for 3 days and
then used for subsequent experiments.
RNA Extraction and Real-Time PCR
Cells were lysed with TRIzol Reagent (Ambion, Grand Island,
NY, USA, https://www.thermoﬁsher.com/hk/en/home/brands/
invitrogen/ambion.html). RNA was converted into cDNA with
M-MuLV Reverse Transcriptase (NEW ENGLAND BioLabs, Ips-
wich, MA, USA, https://www.neb.com/) and random primers
(Invitrogen). Real-time PCR was performed with SYBR Green
Master Mix (Clontech, Mountain View, CA, USA, https://www.
clontech.com/) on an ABI 7500 Fast Real-Time PCR system
(Applied Biosystems, Grand Island, NY, USA, http://www.ther-
moﬁsher.com/hk/en/home/brands/applied-biosystems.html)
according to the manufacturer’s instructions. Primers used for
real-time PCR are listed in Supporting Information Table 1.
qPCR determination of gene level was calculated using the
DDCt method with treatment group compared with baseline
and b-actin serving as internal control.
Immunofluorescence
Cells were plated onto 0.1% gelatin coated coverslips for 48
hours, ﬁxed with 4% paraformaldehyde (Sigma) for 10
minutes at room temperature, washed twice with PBS, per-
meablized with 0.2% Triton-X 100 in PBS with 10% FBS for 30
minutes, and incubated with primary antibodies (Mesp1
(Abcam, 1:100, Cambridge, UK, http://www.abcam.com/), Isl1
(Abcam, 1:100), Nkx2.5 (Santa Cruz, 1:100, Dallas, Texas, USA,
http://www.scbt.com/), a-Actinin (Sigma, 1:1,000), myosin
light chain 2 atrial (Mlc2a, Abcam, 1:100), myosin light chain
2 ventricular (Mlc2v, AXXORA, 1:10, Farmingdale, NY, USA,
http://www.axxora.com/), von Willebrand Factor (vWF) (Milli-
pore, 1:100), a-smooth muscle actin (R&D Systems, 1:100,
Minneapolis, MN, USA, https://www.rndsystems.com/), or
Nanog (Fisher Scientiﬁc, 1:100, Grand Island, NY, USA, https://
www.ﬁshersci.com/)) in blocking buffer (0.1% Triton-X 100 in
PBS with 10% FBS) overnight at 48C. Cells were washed ﬁve
times with PBST (0.1% Triton-X 100 in PBS), ﬁve minutes each
time, and then incubated with secondary antibody Alexa Fluor
594 conjugate for 1 hour. The cells were further counter-
stained and mounted with SlowFade Gold antifade reagent
with DAPI (Invitrogen). For counting Mesp1, Isl1, and Nkx2.5
positive cells, four views per coverslip were counted and
three coverslips were used for each round of experiment. The
experiment was repeated three times.
Flow Cytometry and Cell Purification
Spheres and differentiated cardiomyocytes were dissociated
with 1 mg/ml collagenase B (Roche Life Science) for 30
minutes at 378C, followed by 2 mM EDTA for 5 minutes. Cells
were centrifuged and re-suspended in PBS with 5% FBS. For
cell surface marker staining, cells were ready for use. For car-
diomyocyte marker staining, cells were ﬁxed with 2% parafor-
maldehyde for 15 minutes, then permeablized with 0.5%
Tween 20 for 15 minutes. Cells were stained with primary
antibodies (a-Actinin (Sigma, 1:1,000), myosin light chain 2
atrial (Mlc2a, Abcam, 1:100), myosin light chain 2 ventricular
(Mlc2v, AXXORA, 1:10), cKit (BD Biosciences, 1:100), Flk1 (BD
Biosciences, 1:100), CXCR4 (Abcam, 1:100), PDGFRa (Cell sig-
nal, 1:100, Boston, MA, USA, http://www.cellsignal.com/),
Sca1(Abcam, 1:100), and CD105-FITC/CD45-PE (BD Bioscien-
ces, 1:100)) for 1 hour, washed three times with PBS, then
stained with secondary antibody Alexa Fluor 488 conjugate
for 1 hour. Cells were analyzed with the FC500 (Beckman
Coulter, Inc., Indianapolis IN, USA, https://www.beckman-
coulter.com/) and data analyzed with FlowJo software. cKit,
Flk1, and CXCR4 positive cells were puriﬁed by BD FACSAria
SORP cell sorter (BD Biosciences).
Patch Clamping
The whole-cell patch clamp technique was used [28]. Borosili-
cate glass electrodes (1.2 mm outside diameter) were pulled
with a Brown-Flaming puller (model P-97; Sutter Instrument
Co., Novato, CA, USA, http://www.sutter.com/) with tip resis-
tances of 2–3 MX when ﬁlled with pipette solution (20 mM
Xu, Lee, Ran et al. 2695
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KCl, 110 mM K-aspartate, 1.0 mM MgCl2, 10 mM HEPES,
0.05 mM EGTA, 0.1 mM GTP, 5.0 mM Na2-phosphocreatine,
and 5.0 mM Mg2-ATP; the pH was adjusted to 7.2 with KOH.).
Cells were perfused with Tyrode solution (136 mM NaCl,
5.4 mM KCl, 1.0 mM MgCl2, 1.8 mM CaCl2, 0.33 mM
NaH2PO4, 10 mM glucose, and 10 mM HEPES; the pH was
adjusted to 7.4 with NaOH.). The cellular electrophysiological
parameters were measured in spontaneous beating cardio-
myocytes for differentiated cardiomyocytes and neonatal car-
diomyocytes, and during pacing with 1 Hz for adult
cardiomyocytes. The nodal, atrial, and ventricular like cardio-
myocytes were deﬁned by maximum diastolic membrane
potential, action potential amplitude (APA) and the ratio of
action potential duration at 90% to 50% repolarization
(APD90/50) [27]. Both atrial and ventricular cardiomyocytes
have lower maximum diastolic membrane potential (< 250
mV) while nodal is higher than 250 mV. Both atrial and ven-
tricular cardiomyocytes have higher APA (>90 mV) while nod-
al has lower than 90 mV. Atrial cardiomyocytes have a ratio
of APD90/APD50 more than 2.0 without plateau phase while
ventricular cardiomyocytes have a ratio less than 1.9 with pla-
teau phase.
Calcium Transient
Calcium transient studies were conducted as in our previous
studies [29–32]. In brief, Fluo-4 AM (Invitrogen) was diluted in
culture medium and loaded into the cells with a ﬁnal concen-
tration of 10 lM for 30 minutes at room temperature in the
dark. Cells were washed with Tyrode (1.8 mM CaCl2) solution
and ready for imaging 30 minutes later. The coverslip was
transferred into the glass bottom dish for confocal imaging
(Corning Incorporated, Corning, NY, USA, https://www.corning.
com/). A LSM510 (Zeiss, Oberkochen, Germany, http://www.
zeiss.com/) confocal microscope equipped with a 203 objec-
tive was used for calcium transient recording. The Fluo-4 was
excited by a 488 nm line of an Argon laser and emission sig-
nals above 505 nm were recorded. Line scan mode was used
for recording the calcium transient at 378C, 5% CO2. The Ca
21
level was reported as DF/F0, where F0 is the resting Ca21
ﬂuorescence and DF is F2 F0. F refers to the ﬂuorescence
signal recorded at different time points.
Contractility Measurement
Cell contractility was recorded by MyoCam-S (ION-OPTIX,
Westwood, MA, USA, http://www.ionoptix.com/) and IonWi-
zard software (ION-OPTIX) [33]. The coverslip was transferred
into a perfusion chamber containing Tyrode buffer (1.8 mM
CaCl2) and maintained at 378C. The beating cardiomyocyte cell
edge was identiﬁed by the left and right cursor and located
with IonWizard software under the microscope. The cell edge
movement was recorded at a magniﬁcation of 403 with the
capturing frequency at 250 Hz. Contractility was expressed as
a percentage of cell length shortening, calculated with IonWi-
zard software.
Western Blot
Cells were lysed using RIPA buffer (10 mM Tris-HCl (pH 8.0),
1 mM EDTA, 1% Triton X-100, 0.1% SDS, 140 mM NaCl) with
proteinase inhibitor cocktail (Sigma). The lysate was separated
with 8% SDS-PAGE. Membrane was incubated overnight at
48C with rabbit anti-b-catenin (Abcam 1:1,000), Mesp1
(Abcam, 1:1,000), Isl1 (Abcam, 1:1,000), Nkx2.5 (Santa Cruz,
1:1,000), b-actin (Abcam, 1:4,000). Goat anti-Rabbit IgG
(H1 L)/HRP (horseradish peroxidase) (Dako, 1:2000, Glostrup,
Denmark, http://www.dako.com/) was used as a secondary
antibody and the signal was detected with Clarity ECL West-
ern Blotting Substrate (Bio-Rad, Hercules, CA, USA, http://
www.bio-rad.com/). Band density was measured by Image J
(National Institutes of Health, USA, http://www.ncbi.nlm.nih.
gov/).
Whole Genome Arrays and Data Analysis
Gene expression proﬁle was determined on the GeneChip
Mouse Gene 2.0 ST Array (Affymetrix, Santa Clara, CA, USA,
http://www.affymetrix.com/) at the Genome Center of the
University of Hong Kong. Three microgram of total RNA were
used for cDNA synthesis, fragmentation and hybridization
(Affymetrix). Arrays were scanned with a GeneArray scanner
7G (Affymetrix). Data were background-subtracted and nor-
malized with the Robust Multichip Average method using the
software GeneSpring (Agilent Technologies, Santa Clara, CA,
USA, https://www.agilent.com/). Expression proﬁles were
established on the basis of duplicate samples collected from
independent experiments. Statistical signiﬁcance was deter-
mined with one-way ANOVA test and multiple testing correc-
tions were performed using Benjamini-Hochberg test. p< 0.05
was considered signiﬁcant. All samples were compared against
the group “Fibroblast” and differentially expressed genes
were identiﬁed with a fold change cut-off of >2.0. Hierarchi-
cal clustering was performed with Cluster 3.0 software [34].
Mouse Model of Myocardial Infarction
MI and cell transplantation were performed as before [35].
Coronary occlusion was conﬁrmed by the presence of myocar-
dial blanching at the apex. 1 3 106 cells (20 ll in total, dilut-
ed in 50% Matrigel, BD Biosciences) were injected into the
infarct border zone (left side, right side, and upside of the
infarcted region, three sites in total, 5 ll for each site) and
the infarcted region (one site in the middle of the infarcted
region, 5 ll).
Echocardiography
Four weeks after transplantation, animals were anesthetized
with ketamine 100 mg/kg. The heart was monitored in 2D
mode with Vivid q system (GE Healthcare, Little Chalfont, UK,
http://www.gehealthcare.com/) with a 11.5-MHz transducer
GE 10-RS (GE Healthcare). The image was recorded in 2D
mode in the parasternal long axis view. The M-mode line
passed through the basal segment of the left ventricle
between the mitral valve and the papillary muscle. M-mode
line was adjusted to be perpendicular to the walls of the left
ventricle. Left ventricular ejection fraction was derived from
the measurement of LV end-diastolic diameter and LV end-
systolic diameter in standard M-mode.
Hemodynamic Assessment
Hemodynamic assessment was performed as described before
[35, 36]. At 4 weeks after transplantation, the animals were
anesthetized with ketamine 100 mg/kg and xylazine 10 mg/
kg. The right carotid artery was gently exposed and isolated.
A 1.2-F, 3.5 mm electrode spacing rodent pressure-volume
catheter (Transonic, Ithaca, NY, USA, http://www.transonic.com/)
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connected to ADVantage Small Animal PV Foundation Sys-
tem (Iworx, Dover, NH, USA, https://www.iworx.com/) was
inserted into the artery. Hemodynamic parameters including
left ventricular end systolic pressure, maximum increase in
left ventricular pressure (dP/dt) and the slope of end systol-
ic pressure-volume relationship were recorded and analyzed
with LabScribe2 (Iworx).
Histological Assessment
At 4 weeks after transplantation, the animals were sacriﬁced
and the hearts were ﬁxed with 10% neutral buffered formalin
(Sigma), embedded in parafﬁn. The heart was sectioned (5
lm in thickness) serially from the apex to the base. Every
tenth serial section was chosen for further analysis. Sections
were used for trichrome staining (ScyTek, Logan, UT, USA,
http://www.scytek.com/) or immunohistochemistry [a-Actinin
1:1,000 (Sigma), green ﬂorescence protein (GFP) 1:200 (Santa
Cruz), vWF 1:200 (Millipore)]. The infarcted wall thickness was
measured by the ratio of anterior to septal wall thickness and
the percentage of infarction determined by the ratio of blue
positive area to whole left ventricle. The engraftment was
determined by measuring the GFP positive area and compar-
ing it with the total heart area. The capillary density was mea-
sured by counting the vWF positive capillaries per mm2.
DiR Labeling and Cell Tracking
Cardiospheres were dissociated into single cells by 1 mg/ml
collagenase B, followed by 2 mM EDTA treatment. Single cells
were labeled with DiR (Life Technologies, Waltham, MA USA,
https://www.thermoﬁsher.com/) for 15 minutes and then
washed three times with PBS. Labeled cells were transplanted
into MI mice. At different time points following transplanta-
tion, the mouse was sacriﬁced and the heart was dissected
out for signal detection using the IVIS Spectrum Preclinical In
Vivo Imaging System (PerkinElmer, Waltham , MA, USA,
http://www.perkinelmer.com/). The quantity of DiR labelled
cells in the heart was analyzed using IVIS Spectrum software.
Statistical Analysis
Data were analyzed using SPSS software for Windows (IBM,
Armonk, NY, USA, http://www.ibm.com/) and are shown as
mean6 SEM (standard error of the mean). Student t-test was
used for two group comparison and 1-way ANOVA for multi-
ple group comparison with normal data distribution, paramet-
ric test, and Turkey Post Hoc tests. A level of p< 0.05 was
considered statistically signiﬁcant.
RESULTS
GSK3b Inhibitor-BIO and Oncostatin M Promote
Generation of iCS from Mouse Fibroblasts with
Somatic Reprogramming
Mouse embryonic ﬁbroblast cells were infected with retrovi-
rus expressing three transcription factors (Oct4, Sox2, and
Klf4). Following overnight infection, the medium was
refreshed with Knockout Serum Replacement-based medium
that has been proven to be a more efﬁcient system for
somatic reprogramming [37]. Quantitative PCR analysis
showed that the mRNA level of cardiac progenitor markers
Isl1 and Nkx2.5 was signiﬁcantly upregulated during somatic
reprogramming, starting from day 16 (for Isl1) and day 18
(for Nkx2.5) compared with the control green ﬂuorescence
protein (GFP) vector at day 6 post retrovirus infection. The
mRNA level of Isl1 and Nkx2.5 in cells infected with control
GFP remained unchanged at day 22 compared with day 6
(Fig. 1A). The mRNA level of mesoderm marker Bry, another
cardiac marker Gata4 and early cardiac progenitor marker
Mesp1 were also upregulated compared with the control GFP
(Fig. 1B). Nonetheless Mesp1 declined at day 20 compared
with day 16 (Fig. 1B). As a result, day 18 post infection was
chosen as the experimental time point for the next screening
step, when both early (Mesp1) and late (Nkx2.5) cardiac pro-
genitor markers maintained a higher level of expression (Fig.
1A, 1B).
A total of 12 growth factors and chemicals were tested:
EGF, bFGF, Wnt3a, BIO, lithium chloride, VEGF, Activin A, HGF,
OSM, Interleukin 6, CT-1, and BMP4. Among them, EGF, bFGF,
Wnt3a, BIO, and OSM signiﬁcantly boosted the mRNA level of
all Mesp1, Isl1, and Nkx2.5 compared with the basal medium
(Fig. 1C). Some other factors also elevated the mRNA level of
Isl1 or Nkx2.5 or Isl1 and Nkx2.5, but not Mesp1, and includ-
ed lithium chloride, VEGF, HGF, CT-1, and BMP4. As BIO and
OSM enhanced the mRNA level of Isl1 more than other fac-
tors (Fig. 1C), we further determined whether a combination
of these two factors could provide an additive effect. Indeed,
combining these two factors signiﬁcantly increased the mRNA
level of Mesp1, Isl1, and Nkx2.5 (Fig. 1D). Nonetheless adding
a further growth factor into the medium with BIO and OSM
did not further increase the same mRNA levels (Fig. 1D).
After plating the cells onto poly-D-lysine coated plates,
which were used for cardiosphere formation and isolation [9],
cells treated with BIO and OSM, not those untreated, began
to aggregate as spheres (Fig. 1E). These spheres, formed dur-
ing somatic reprogramming with BIO and OSM treatment,
contained Mesp1, Isl1, and Nkx2.5 positive cells (Supporting
Information Fig. 1A). They had the capability to form beating
cluster of cardiomyocytes after 12 days of differentiation; and
the number of beating cluster reached a maximum at 15
days. Those beating cardiomyocytes expressed different cardi-
omyocytes markers including a-Actinin, myosin light chain 2
atrial (atrial speciﬁc marker), and myosin light chain 2 ventric-
ular (ventricular speciﬁc marker) (Supporting Information Fig.
1B and Movie 1). Furthermore, the differentiated cells also
contained vWF and a-smooth muscle actin positive cells, indi-
cating their endothelium and smooth muscle differentiation
capability (Supporting Information Fig. 1C, 1D).
Cell surface marker analysis for cardiospheres revealed
that both spheres and no-sphere forming cells derived from
reprogramming contained similar high proportion of Sca1
positive and CD105highCD45negative cells as eCS (Supporting
Information Fig. 1E). Conversely, spheres forming cells and
eCS contained signiﬁcantly higher population of cKit, Flk1,
and CXCR4 positive cells comparing to non-sphere forming
cells (Supporting Information Fig. 1E). Moreover, those
spheres forming cells were further enriched with cells
expressing cKit, Flk1, and CXCR4 on further passage (Support-
ing Information Fig. 1F). Puriﬁed cKit, Flk1, or CXCR4 positive
cells from those spheres forming cells had the capability to
differentiate into a-Actinin positive cardiomyocytes but not
those negative populations (Supporting Information Fig. 1G).
Furthermore, qPCR analysis revealed that these spheres did
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Figure 1. BIO and OSM elevated the mRNA level of cardiac progenitor marker Mesp1, Isl1, and Nkx2.5 and promoted sphere formation
in embryonic ﬁbroblasts. (A): qPCR analysis of Isl1 and Nkx2.5 showed that their mRNA level in reproprogramming ﬁbroblasts was over-
expressed with SKO (Sox2, Klf4, and Oct4) when the cells were cultured in basal medium compared with GFP from day 6 (D6) to day 22
(D22) during somatic reprogramming (n5 3, biological replicates; *p< .05; day time point of interest vs. D6 GFP group); (B) qPCR analy-
sis of mesodermal marker Bry, early cardiac progenitor marker Mesp1 and cardiac marker Gata4 showed that their mRNA level
increased from Day 16 (D16) to Day 20 (D20) during reprogramming and Mesp1 tended to decrease from Day 16 to Day20 (n5 3, bio-
logical replicates; *p< .05; day time point of interest vs. D6 GFP group); (C) qPCR analysis of Mesp1, Isl1, and Nkx2.5 for cardiotrophic
growth factors or small molecule screening at Day 18 after reprogramming (n5 3, biological replicates; *p< .05; treatment group vs.
basal group, unless indicated by arrows); (D) qPCR analysis of Mesp1, Isl1, and Nkx2.5 for the combination of BIO and OSM at Day 18
of reprogramming demonstrated their synergistic effects (n5 3, biological replicates; *p< .05; indicated by arrows); (E) Sphere forma-
tion appeared with BIO and OSM treatment. The ﬁgure shows the sphere morphology of induced cardiospheres cultured on poly-D-lysin
coated plates after 18 days of reprogramming. No spheres formed in basal meidum without BIO and OSM (middle pannle) after plating
onto poly-D-lysin coated plates. Scale bar: 500 lm. Abbreviations: bFGF, basic ﬁbroblast growth factor; BIO, (20Z,30E)- 6-Bromoindirubin-
30-oxime; Bmp4, bone morphogenetic protein 4; CT-1, cardiotrophin-1; EGF, epidermal growth factor; GFP, green ﬂuorescent protein;
HGF, hepatocyte growth factor; IL-6, Interleukin 6; OSM, Oncostatin-M; VEGF, vascular endothelial growth factor; Wnt3, Wingless-Type
MMTV Integration Site Family, Member 3.
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Figure 2. Functional comparison of iCS generated from adult skin ﬁbroblasts and eCS. (A): iCS contained more Mesp1, Isl1, and Nkx2.5
positive cells than eCS via immunostaining (n5 3; *p< 0.05; iCS vs. eCS) at day 2 after shere formation; (B) After 15 days of cardisphere
formation, both iCSs and eCSs had a similar cardiomyocyte differentiation capability shown by measuring a-Actinin and Mlc2a and
Mlc2v positive cell ﬂow cytometry analysis (n5 3); (C) Both iCS (n5 63), and eCS (n5 50) had a similar capability to differentiate into
nodal, atrial, and ventricular-like cardiomyocytes as determined by resting membrane potential and action potential (AP) morphology
measured by whole cell patch clamp; (D) Cardiomyocytes differentiated from iCSs had similar electrophysiological properties to eCS and
mESC- derived cardiomyocytes and neonatal cardiomyocytes from the perspective of maximum diastolic potential, action potential
amplitude, APD90, and maximal membrane potential upstroke velocity via patch clamp (n5 55 for iCS derived cardiomyocytes; n5 42
for eCS-derived cardiomyocytes; n5 20 for mESC-derived cardiomyocytes, neonatal and adult cardiomyocytes), *p< 0.05 as indicated
with arrows; (E) Cardiomyocytes differentiated from iCS had similar calcium handling properties to eCS- and mESC-derived cardiomyo-
cytes (n5 10), *p< 0.05 as indicated with arrows; (F) Cardiomyocytes differentiated from iCSs had similar cell contractility to eCS- and
mESC-derived cardiomyocytes and neonatal cardiomyocytes (n5 10); (G) Whole genome gene expression proﬁle showed iCS clustered
with eCS but not ﬁbroblast (n5 2). Abbreviations: APD90, action potential duration at 90% repolarization; eCS, endogenous cardio-
spheres; iCS, induced cardiospheres; mESC, mouse embryonic stem cell; Mlc2a, myosin light chain 2 atrial; Mlc2v, myosin light chain 2
ventricular.
not express pluripotent stem cell marker Oct, Sox2, Nanog,
or Rex1, conﬁrming that they did not contain pluripotent
stem cells. These ﬁndings were further conﬁrmed by
immune-staining of Nanog in the dissociated spheres (Sup-
porting Information Fig. 1H, 1I).
The reprogramming approach using BIO and OSM treat-
ment of mouse embryonic ﬁbroblasts was also applied to
adult skin ﬁbroblasts. Similarly, the spheres generated from
adult skin ﬁbroblasts contained Mesp1, Isl1, and Nkx2.5 posi-
tive cells (Supporting Information Fig. 2) and could differenti-
ate into beating cardiomyocytes (Supporting Information
Movie 2). The spheres generated by this approach using
somatic reprogramming of pluripotent factors followed by BIO
and OSM treatment in either mouse embryonic ﬁbroblasts or
adult skin ﬁbroblasts are termed iCS. In general, beating clus-
ters of cardiomyocytes were observed at 32–35 days of cultur-
ing from ﬁbroblasts: 18 days for reprogramming and factor
induction, 2 days for sphere formation, and 12–15 days for
cardiomyocytes differentiation. This reprogramming and differ-
entiation approaches are highly consistent and effective for
both mouse embryonic (repeated 13 times) and adult skin
ﬁbroblast (repeated 45 times) cells for generation of iCS. In
subsequent experiments, iCS generated from adult skin ﬁbro-
blasts were used for further functional assessment.
Comparison of iCS with eCS and Native
Cardiomyocytes
Compared with eCS isolated from the mouse heart, those iCS
derived from adult skin ﬁbroblasts contained a higher per-
centage of Mesp1, Isl1, and Nkx2.5 positive cells (Fig. 2A and
Supporting Information Fig. 2). Nevertheless, both types of
cardiospheres showed similar efﬁcacy for in vitro cardiac dif-
ferentiation when the percentage of a-Actinin, myosin light
chain 2 atrial, and myosin light chain 2 ventricular positive
cells were analyzed (Fig. 2B). Using the patch clamp tech-
nique, the action potential was recorded from a single isolat-
ed cardiomyocyte to characterize the phenotype of these
cells. As deﬁned by the ratio of action potential duration
(APD) at 90% to 50% repolarization [27], both types of cardio-
sphere showed a similar level of differentiated nodal-like, atri-
al-like, and ventricular-like cardiomyocytes (Fig. 2C; Supporting
Information Fig. 3).
Next, we further compared the functional phenotypes of
cardiomyocytes derived from these two types of cardio-
spheres (iCS and eCS) and mESC with freshly isolated mouse
native cardiomyocytes (neonatal and adult cardiomyocytes).
They demonstrated similar maximum diastolic potential, APA,
APD at 90% repolarization and the maximal membrane poten-
tial upstroke velocity. Nonetheless the adult cardiomyocytes
had a signiﬁcantly shorter APD at 90% repolarization com-
pared with other cardiomyocytes (Fig. 2D).
Calcium transient analysis showed that the iCS, eCS, and
mESC derived cardiomyocytes had similar level of calcium
amplitude and duration of calcium transient. But these differ-
entiated cardiomyocytes had a signiﬁcantly lower calcium sig-
nal upstroke velocity than native cardiomyocytes (Fig. 2E).
Assessment of cell contractile function showed that cardio-
myocytes from different sources had a similar percentage of
cell shortening (Fig. 2F). Our results demonstrated that the in
vitro functional parameters of cardiomyocytes derived from
eCSs, iCSs, or mESCs were similar; but were less mature
compared with native cardiomyocytes. Whole genome expres-
sion proﬁle analysis showed that the iCS was clustered with
eCS but the ﬁbroblast cells (Fig. 2G), further proving the simi-
larity of iCS and eCS.
Transplantation of iCS Improves Cardiac Function
Following Myocardial Infarction
We investigated the therapeutic effects of transplanting iCS
versus eCS into an animal model of acute MI in immunodeﬁ-
cient mice (NOD/SCID). Compared with phosphate-buffered
saline or the iCS parental ﬁbroblast cell injection, both iCS
and eCS transplantation signiﬁcantly improved left ventricular
ejection fraction at week 4 after cell transplantation as deter-
mined by serial echocardiogram (Fig. 3A, 3B). Invasive hemo-
dynamic assessment at week 4 also conﬁrmed that compared
with saline or ﬁbroblast injection, both iCS and eCS transplan-
tation improved left ventricular end systolic pressure, maxi-
mum increase in left ventricular pressure and the slope of
end systolic pressure-volume relationship (Fig. 3C, 3D).
Histological examination with Trichrome staining showed
that iCS and eCS transplantation signiﬁcantly increased anteri-
or/septal ventricular wall thickness and reduced infarct size
(Fig. 3E--3G). In vivo tracking of the transplanted cells using
DiR labeling revealed that transplanted iCSs and eCSs were
engrafted into the myocardium at a similar level and
remained detectable 12 weeks after transplantation. Never-
theless, the average radiant efﬁciency of DiR was signiﬁcantly
reduced at week 4 compared with 5 minutes after cell trans-
plantation (week 0) and this was further reduced at week 12
(Fig. 4A, 4B).
To further determine the fate of the transplanted cells,
they were labeled with lentivirus expressing GFP and then
transplanted into MI mice. The GFP positive cells were
engrafted in the mouse heart at a similar level and double
staining for GFP and a-Actinin showed that the transplanted
iCS and eCS had the potential for in vivo differentiation into
cardiomyocytes 4 weeks after cell transplantation
(Fig. 4C, 4D).
In addition, transplantation of both iCS and eCS signiﬁ-
cantly increased the capillary density as determined by vWF
staining of the peri-infarct region and infarcted region com-
pared with saline injection (Fig. 4E, 4F). In addition, double
staining of GFP and vWF revealed potential endothelial cell
differentiation of transplanted iCS or eCS (Supporting Informa-
tion Fig. 4). In summary, iCS have similar therapeutic effects
to eCS and improve cardiac function following MI. Of note,
no tumor formation was observed 12 weeks following
transplantation.
Induction of Cardiosphere Formation from Fibroblasts
by BIO and OSM via b-Catenin
b-catenin is stabilized by the Gsk3b inhibitor-BIO and is criti-
cal for the maintenance of cardiac progenitor cells [38, 39].
Accordingly, we hypothesized that BIO and OSM induced car-
diosphere formation via upregulation of b-catenin. Indeed,
both BIO and OSM alone or in combination increased the pro-
tein level of b-catenin as well as the expression of Mesp1,
Isl1, and Nkx2.5 when compared with basal medium without
BIO and OSM (Fig. 5A). Knocking down b-catenin through
shRNA decreased the protein level of Mesp1, Isl1, and Nkx2.5
compared with cells infected with scramble shRNA (Fig. 5B),
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Figure 3. Transplantation of iCS improves cardiac function as eCS following MI. (A): Representative M-mode echocardiographic tracing
at week 4 after MI induction and cardiosphere transplantation showed cardiac function improvement; (B) Assessment of LVEF by echo-
cardiogram at week 4 after cell transplantation showed both iCSs and eCSs achieved a similar level of cardiac function improvement
(n5 8); *p< 0.05; as indicated by arrows; (C) Representative tracing of the pressure-volume loop assessment to measure slope of
ESPVR at week 4 after cell transplantation showing cardiac function improvement; (D) Hemodynamic assessment at week 4 after cell
transplantation showed both iCS and eCS achieved a similar level of cardiac function improvement (n5 8); *p< 0.05; as indicated by
arrows; (E) Trichrome staining of parafﬁn embedded heart sections at week 4 after cell transplantation indicated wall thickness increase
and infarct size decrease. The blue region between the dark lines indicates the infarcted region; the black frame indicates the region
(middle of the septum) for septal thickness measurement; Scale bar: 1 mm. (F): Left ventricular wall thickness was measured by the
ratio of anterior to septal wall thickness at week 4 after cell transplantation and indicated that both iCS and eCS had a similar increase
in wall thickness (n5 8); *p< 0.05; as indicated by arrows; (G) Infarct size measurement by the percentage area with collagen deposit
using trichrome staining at week 4 after cell transplantation indicated both iCS and eCS achieved a similar decrease in infarct size
(n5 8); *p< 0.05; as indicated by arrows. Abbreviations: 1dP/dt, peak rate of pressure rise; eCS, endogenous cardiospheres; ESPVR,
end systolic pressure-volume relationship; iCS, induced cardiospheres; LV, left ventricular; LVEF5 left ventricular ejection fraction; LVESP,
left ventricular end systolic pressure; MI, myocardial infarction; Pre-MI, before myocardial infarction.
Figure 4. Transplanted iCS participate in cardiac regeneration in vivo and promote angiogenesis as eCS. (A): Representative ﬁgures of
DiR labeled cells in the heart at week 0 (5 minutes after cell transplantation), week 4 and week 12 after cell transplantation in a mouse
model of myocardial infarction, heatmap showed the average radiant efﬁciency; (B) Average radiant efﬁciency of DiR labeled cells in the
heart after cell transplantation indicated both iCS and eCS achieved similar engraftment and were still detectable at week 12 (n5 8);
*p< 0.05; as indicated by arrows; (C) Immunostaining of parafﬁn embedded heart sections at week 4 after cell transplantation with a-
Actinin and GFP which indicates that the transplanted cardiospheres participated in cardiac regeneration; Scale bar: 200 lm. (D): Cell
engraftment measured by immunohistochemistry showed both iCS and eCS achieved a similar level of cell engraftment (up panel,
n5 8). (E): vWF staining of parafﬁn embedded heart sections showed that capillary density increased after transplantation of iCS and
eCS, dark arrow indicates the vWF positive capillary; Scale bar: 100 lm. (F): Peri-infarct and infarcted region capillary number counting
showed both iCS and eCS increased capillary density to a similar degree (n5 8; *p< 0.05; as indicated by arrows). Abbreviations: eCS,
endogenous cardiospheres; GFP, green ﬂuorescent protein; iCS, induced cardiospheres; MI, myocardial infarction; Pre-MI, before myocar-
dial infarction; vWF, von Willebrand Factor.
Figure 5. The BIO and OSM induced cardiosphere (iCS) generation through b-catenin pathway in adult skin ﬁbroblasts infected with
SKO (Sox2, Klf4, and Oct4) treated with BIO or OSM or BIO and OSM. (A): Western blot of b-catenin, Mesp1, Isl1, and Nkx2.5 at day 15
after iCS formation. Representative immunoblot (left panel) and band density measurement (right panel) showed the b-catenin level
was elevated by BIO and OSM stimulation, similar to Mesp1, Isl1, and Nkx2.5 (n5 3; *p< 0.05; groups with growth factors vs. basal
group); Basal: medium without BIO and OSM. (B): Representative immunoblot (left panel) and band density measurement (right panel)
showed b-catenin level was decreased by shRNA knock down, with corresponding supression of Mesp1, Isl1, and Nkx2.5 expression
(n5 3; *p< 0.05; sh-catenin vs. scramble group); (C) Sphere number count after knocking down b-catenin showed that iCS formation
decreased with knock down of b-catenin level in the presence of BIO and OSM (n5 3; *p< 0.05; sh-catenin vs. scramble group); (D)
Representative western blot (left panel) and band density measurement (right panel) indicated overexpression of b-catenin in the
absence of BIO and OSM induced b-catenin that promotes Mesp1, Isl1, and Nkx2.5 expression (n5 3;*p< 0.05; pMXs-b-catenin vs. GFP
group); (E) Cardiosphere number count after overexpressing b-catenin without BIO and OSM treatment showed b-catenin could pro-
mote iCS formation (n5 3; *p< 0.05; pMXs-b-catenin overexpression vs. GFP group). Abbreviations: BIO, (20Z,30E)- 6-Bromoindirubin-30-
oxime; GFP, green ﬂuoresent protein; OSM, Oncostatin-M.
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and reduced cardiosphere formation (Fig. 5C). Nonetheless
overexpressing b-catenin upregulated the protein level of
Mesp1, Isl1, and Nkx2.5 compared with GFP (Fig. 5D), and
promoted the formation of cardiospheres in the absence of
BIO and OSM (Fig. 5E). These ﬁndings conﬁrm the critical role
of b-catenin in the induction of cardiosphere formation from
ﬁbroblasts.
Induction of Cardiosphere Formation from Human
Fibroblasts
We further attempted the generation of iCS from human skin
ﬁbroblast. Human iCS could be successfully generated via the
same reprogramming approach as the mouse skin ﬁbroblast
(Supporting Information Fig. 5A). Those cells derived from the
human iCS were positive for cardiac progenitor cell markers
Mesp1, Isl1, and Nkx2.5 (Supporting Information Fig. 5B).
While the differentiated cardiomyocytes were positive for a-
Actinin, Mlc-2a and Mlc-2v (Supporting Information Fig. 5C),
no spontaneously beating could be observed as previous
reported in human eCS [8, 9]. Nevertheless, those differentiat-
ed cardiomyocytes had functional calcium transient activity
and responded to caffeine stimulation (Supporting Informa-
tion Fig. 5D).
DISCUSSION
Cardiac progenitor cells have been proposed as a novel thera-
py for the treatment of MI. Cardiospheres are a type of cardi-
ac progenitor cell that is potentially safe and effective for
cardiac regeneration following MI in both animal [40] and
human [20] studies. Nevertheless, the widespread clinical
application of autologous eCS is limited by the need for inva-
sive harvesting, and their number, proliferation and differenti-
ation ability decline during the aging process [17, 19, 40, 41].
Direct reprogramming of ﬁbroblasts into cardiomyocytes is
another promising approach to achieve cardiac regeneration
but is limited by the low conversion rate and the potential
arrhythmia risk associated with cardiomyocyte transplantation.
We present a new strategy to generate iCS from adult mouse
skin ﬁbroblasts using a cocktail approach with expression of
pluripotent stem cell factors and combination of Gsk3b
inhibitor-BIO and OSM. Furthermore, human iCS can be gen-
erated using similar approach. Our results suggest that these
cardiotrophic growth factors induce cardiosphere formation
via upregulation of b-catenin. These iCS are capable of differ-
entiation into functional cardiomyocytes in vitro, from the
perspective of action potential and calcium transient, and
incorporate into the myocardium in a MI model as eCS with
subsequent cardiac function improvement. This study provides
the ﬁrst proof-of-principle results that demonstrate the feasi-
bility of generating donor-speciﬁc iCS via a somatic reprog-
ramming process, providing a new source of cell therapy for
treatment of MI.
First, we used the expression of a panel of cardiac tran-
scription factors including Mesp1, Isl1, and Nkx2.5 to screen
for the optimal cocktail of cardiotrophic growth factors for iCS
formation after reprogramming with pluripotent stem cell fac-
tors. These transcription factors have been shown via lineage
tracing studies to be important for heart development and
maintenance of cardiac progenitor cells [13–15]. Quantitative
real-time PCR analysis showed that all these markers were
upregulated during somatic reprogramming and were further
enhanced after adding two more cardiotrophic factors, Gsk3b
inhibitor-BIO and OSM. Sphere formation could be observed
after seeding the cells onto poly-D-lysine coated plates as
described in the isolation of eCS [8, 9, 19]. These iCS generat-
ed from this somatic reprogramming approach were positive
for all three cardiac progenitor markers Mesp1, Isl1, and
Nkx2.5 and had the capability to differentiate into functional
cardiomyocytes. The iCSs contained only a different propor-
tion of Mesp1, Isl1, and Nkx2.5 positive cells, indicating that
they were a mixed cell population, in accordance with previ-
ous reports [9, 19, 40].
The cardiomyocytes derived from the iCS generated from
adult skin ﬁbroblasts were comparable with those derived
from eCS and mESC in terms of cellular electrophysiology, cal-
cium handling, and contractile function. Moreover, transplan-
tation of the iCS following MI provided similar improvement
to that of eCS in terms of cardiac function, reduction in
infarct size and increased capillary density, consistent with
previous ﬁndings in eCS [7].
Our results also provide novel insight into the mechanism
of cardiosphere formation. b-catenin is an important regula-
tor of cardiac progenitor cell fate maintenance, proliferation
and cardiomyocyte differentiation [42]. It directly regulates
isl1 expression [43] and loss of b-catenin decreases the cardi-
ac progenitor population and leads to failure in heart devel-
opment [44]. It is well known that Gsk3b inhibitor-BIO is a
stabilizer of b-catenin that is critical for heart development
[38, 39]. While the action of OSM on b-catenin is unknown,
prior studies have shown that it promotes cardiomyocyte
dedifferentiation and cardiac progenitor cell proliferation in
both MI and heart failure [45]. Here, we demonstrated the
pivotal role of b-catenin in the formation of iCS. Both BIO
and OSM signiﬁcantly increased the protein level of b-
catenin. Manipulating the expression of b-catenin during the
formation of iCS signiﬁcantly affected the efﬁciency of gener-
ation of iCS.
This study had several limitations. First, the use of retrovi-
rus vector may limit the clinical application of this approach.
Whether the use of other nonintegrated vectors or small mol-
ecules for reprogramming can provide similar efﬁcacy remains
unclear. Second, the iCS contains a mixed progenitor cell pop-
ulation as in the eCS. Therefore, the contribution of different
types of progenitor cells in iCS to cardiac differentiation and
regeneration needs to be further investigated. Third, the long-
term safety and efﬁcacy of iCS transplantation are unknown.
Although we did not observe any tumor formation after 3
months, the proarrhythmic risk of iCS transplantation was not
addressed in this study and their long-term therapeutic efﬁca-
cy is unclear. Finally, the low retention of transplanted cells
hinders the potential applications, which is one of the most
important issues should be addressed in the cell therapy ﬁeld
for MI.
CONCLUSION
iCS generated from adult skin ﬁbroblasts by somatic reprog-
ramming and a cocktail of Gsk3b inhibitor-BIO and OSM may
represent a novel source for cell therapy in MI.
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